← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable — 2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 2.0% below its 1-year high (as of 2026-09-17). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 8.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
HUBG
Hub Group, Inc.
Valuation N/A
Industrials Risk 40 · Elevated
Price$36.04
Model IV—
P/IV—
Limited data — see page
HUBS
HUBSPOT INC
Valuation N/A
Technology Risk 42 · Elevated
Price$241.96
Model IV—
P/IV—
Market implies +44.8%/yr vs model +20.8% · above model
HUDI
Huadi International Group Co., Ltd.
Valuation N/A
Basic Materials Risk 43 · Elevated
Price$0.75
Model IV—
P/IV—
Market implies +21.1%/yr vs model +8.0% · above model
HUHU
HUHUTECH International Group Inc.
Valuation N/A
Basic Materials Risk 40 · Elevated
Price$3.95
Model IV—
P/IV—
Market implies +33.4%/yr vs model +8.0% · above model
HUMA
Humacyte, Inc.
Valuation N/A
Healthcare Risk 47 · Elevated
Price$0.57
Model IV—
P/IV—
Market implies +69.5%/yr vs model +15.0% · above model
HURA
TuHURA Biosciences, Inc./NV
Valuation N/A
Healthcare Risk 46 · Elevated
Price$2.05
Model IV—
P/IV—
Limited data — see page
HUT
Hut 8 Corp.
Valuation N/A
Financial Services Risk 34 · Moderate
Price$87.09
Model IV—
P/IV—
Market implies +58.3%/yr vs model +47.2% · above model
HVII
Hennessy Capital Investment Corp. VII
Valuation N/A
Utilities
Price$9.54
Model IV—
P/IV—
Limited data — see page
HVIIR
Hennessy Capital Investment Corp. VII
Valuation N/A
Utilities
Price$0.33
Model IV—
P/IV—
Limited data — see page
HVMC
Highview Merger Corp.
Valuation N/A
Financial Services
Price$10.25
Model IV—
P/IV—
Limited data — see page
HVT
HAVERTY FURNITURE COMPANIES INC
Valuation N/A
Consumer Cyclical Risk 53 · Elevated
Price$27.32
Model IV—
P/IV—
Limited data — see page
HWH
HWH International Inc.
Valuation N/A
Consumer Defensive Risk 37 · Moderate
Price$2.15
Model IV—
P/IV—
Market implies +15.8%/yr vs model +15.0% · in line
HXHX
Haoxin Holdings Ltd
Valuation N/A
Industrials Risk 46 · Elevated
Price$0.47
Model IV—
P/IV—
Market implies -9.6%/yr vs model +4.5% · below model
HYFT
MindWalk Holdings Corp.
Valuation N/A
Healthcare Risk 32 · Moderate
Price$1.31
Model IV—
P/IV—
Limited data — see page
HYI
Western Asset High Yield Opportunity Fund Inc.
Valuation N/A
Unknown
Price$10.20
Model IV—
P/IV—
Limited data — see page
HYLN
Hyliion Holdings Corp.
Valuation N/A
Consumer Cyclical Risk 35 · Moderate
Price$3.90
Model IV—
P/IV—
Market implies +65.5%/yr vs model +8.0% · above model
HYMC
HYCROFT MINING HOLDING CORP
Valuation N/A
Basic Materials Risk 42 · Elevated
Price$21.18
Model IV—
P/IV—
Market implies +90.5%/yr vs model +5.0% · above model
HYPD
HYPERION DEFI, INC.
Valuation N/A
Healthcare Risk 37 · Moderate
Price$3.49
Model IV—
P/IV—
Market implies +92.8%/yr vs model +2.0% · above model
HYT
BLACKROCK CORPORATE HIGH YIELD FUND, INC.
Valuation N/A
Unknown
Price$8.13
Model IV—
P/IV—
Limited data — see page
IAC
IAC Inc.
Valuation N/A
Technology Risk 44 · Elevated
Price$44.53
Model IV—
P/IV—
Market implies +46.5%/yr vs model -0.3% · above model
IACO
Idea Acquisition Corp.
Valuation N/A
Financial Services Risk 33 · Moderate
Price$9.99
Model IV—
P/IV—
Limited data — see page
IAE
Voya Asia Pacific High Dividend Equity Income Fund
Valuation N/A
Unknown
Price$8.81
Model IV—
P/IV—
Limited data — see page
IAF
ABRDN AUSTRALIA EQUITY FUND, INC.
Valuation N/A
Unknown
Price$12.96
Model IV—
P/IV—
Limited data — see page
IAG
IAMGOLD CORP
Valuation N/A
Basic Materials Risk 33 · Moderate
Price$20.26
Model IV—
P/IV—
Limited data — see page
IAU
ISHARES GOLD TRUST
Valuation N/A
Financial Services Risk 33 · Moderate
Price$80.78
Model IV—
P/IV—
Limited data — see page
IAUM
iShares Gold Trust Micro
Valuation N/A
Financial Services Risk 51 · Elevated
Price$43.33
Model IV—
P/IV—
Limited data — see page
IAUX
i-80 Gold Corp.
Valuation N/A
Basic Materials Risk 42 · Elevated
Price$1.75
Model IV—
P/IV—
Market implies +38.1%/yr vs model +0.0% · above model
IBACR
IB Acquisition Corp.
Valuation N/A
Financial Services Risk 36 · Moderate
Price$0.13
Model IV—
P/IV—
Limited data — see page
IBG
Innovation Beverage Group Ltd
Valuation N/A
Consumer Defensive Risk 33 · Moderate
Price$0.98
Model IV—
P/IV—
Market implies +25.6%/yr vs model +2.0% · above model
IBIO
iBio, Inc.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$1.21
Model IV—
P/IV—
Market implies +55.1%/yr vs model +2.0% · above model
IBIT
iShares Bitcoin Trust ETF
Valuation N/A
Financial Services Risk 47 · Elevated
Price$44.74
Model IV—
P/IV—
Limited data — see page
IBN
ICICI BANK LTD
Valuation N/A
Financial Services
Price$29.39
Model IV—
P/IV—
Limited data — see page
IBO
IMPACT BIOMEDICAL INC.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$0.46
Model IV—
P/IV—
Market implies +85.3%/yr vs model +2.0% · above model
IBRX
ImmunityBio, Inc.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$7.91
Model IV—
P/IV—
Market implies +44.8%/yr vs model +50.0% · below model
ICCM
IceCure Medical Ltd.
Valuation N/A
Healthcare Risk 46 · Elevated
Price$2.21
Model IV—
P/IV—
Market implies +92.2%/yr vs model +2.0% · above model
ICL
ICL Group Ltd.
Valuation N/A
Basic Materials Risk 42 · Elevated
Price$5.58
Model IV—
P/IV—
Limited data — see page
ICON
Icon Energy Corp
Valuation N/A
Industrials Risk 49 · Elevated
Price$0.92
Model IV—
P/IV—
Market implies -35.5%/yr vs model +15.0% · below model
ICU
SeaStar Medical Holding Corp
Valuation N/A
Healthcare Risk 29 · Moderate
Price$3.03
Model IV—
P/IV—
Market implies +13.7%/yr vs model +15.0% · in line
ICUCW
SeaStar Medical Holding Corp
Valuation N/A
Healthcare Risk 29 · Moderate
Price$0.02
Model IV—
P/IV—
Market implies -50.0%/yr vs model +15.0% · below model
IDAI
T Stamp Inc
Valuation N/A
Technology Risk 27 · Moderate
Price$3.20
Model IV—
P/IV—
Market implies +37.1%/yr vs model +2.0% · above model
IDCC
InterDigital, Inc.
Valuation N/A
Financial Services Risk 58 · Elevated
Price$350.13
Model IV—
P/IV—
Limited data — see page
IDE
Voya Infrastructure, Industrials & Materials Fund
Valuation N/A
Unknown
Price$12.71
Model IV—
P/IV—
Limited data — see page
IDR
Idaho Strategic Resources, Inc.
Valuation N/A
Basic Materials Risk 47 · Elevated
Price$30.91
Model IV—
P/IV—
Market implies +68.6%/yr vs model +8.0% · above model
IE
Ivanhoe Electric Inc.
Valuation N/A
Basic Materials Risk 42 · Elevated
Price$10.40
Model IV—
P/IV—
Market implies +83.3%/yr vs model +0.0% · above model
IEAG
Infinite Eagle Acquisition Corp.
Valuation N/A
Financial Services
Price$10.22
Model IV—
P/IV—
Limited data — see page
IEAGR
Infinite Eagle Acquisition Corp.
Valuation N/A
Financial Services
Price$0.16
Model IV—
P/IV—
Limited data — see page
IFN
ABERDEEN INDIA FUND, INC.
Valuation N/A
Unknown
Price$11.15
Model IV—
P/IV—
Limited data — see page
IFRX
InflaRx N.V.
Valuation N/A
Healthcare Risk 32 · Moderate
Price$2.12
Model IV—
P/IV—
Limited data — see page
IFS
Intercorp Financial Services Inc.
Valuation N/A
Financial Services Risk 35 · Moderate
Price$54.73
Model IV—
P/IV—
Limited data — see page
IGA
Voya Global Advantage & Premium Opportunity Fund
Valuation N/A
Unknown
Price$10.42
Model IV—
P/IV—
Limited data — see page
IGAC
Invest Green Acquisition Corp
Valuation N/A
Financial Services
Price$10.05
Model IV—
P/IV—
Limited data — see page
IGACR
Invest Green Acquisition Corp
Valuation N/A
Financial Services
Price$0.16
Model IV—
P/IV—
Limited data — see page
IGC
IGC Pharma, Inc.
Valuation N/A
Healthcare Risk 31 · Moderate
Price$0.28
Model IV—
P/IV—
Market implies +46.9%/yr vs model +2.0% · above model
IGD
Voya GLOBAL EQUITY DIVIDEND & PREMIUM OPPORTUNITY FUND
Valuation N/A
Unknown
Price$6.33
Model IV—
P/IV—
Limited data — see page
IGI
Western Asset Investment Grade Opportunity Trust Inc.
Valuation N/A
Unknown
Price$15.67
Model IV—
P/IV—
Limited data — see page
IGR
CBRE GLOBAL REAL ESTATE INCOME FUND
Valuation N/A
Unknown
Price$12.63
Model IV—
P/IV—
Limited data — see page
IHD
Voya Emerging Markets High Dividend Equity Fund
Valuation N/A
Unknown
Price$7.67
Model IV—
P/IV—
Limited data — see page
IHG
INTERCONTINENTAL HOTELS GROUP PLC /NEW/
Valuation N/A
Consumer Cyclical Risk 36 · Moderate
Price$153.83
Model IV—
P/IV—
Limited data — see page
IHS
IHS Holding Ltd
Valuation N/A
Communication Services Risk 44 · Elevated
Price$8.47
Model IV—
P/IV—
Limited data — see page
IHT
INNSUITES HOSPITALITY TRUST
Valuation N/A
Financial Services Risk 62 · High
Price$1.30
Model IV—
P/IV—
Limited data — see page